The 2013 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension
Daniel G Hackam,Robert R Quinn,Pietro Ravani,Doreen M Rabi,Kaberi Dasgupta,Stella S Daskalopoulou,Nadia A Khan,Robert J Herman,Simon L Bacon,Lyne Cloutier,Martin Dawes,Simon W Rabkin,Richard E Gilbert,Marcel Ruzicka,Donald W McKay,Tavis S Campbell,Steven Grover,George Honos,Ernesto L Schiffrin,Peter Bolli,Thomas W Wilson,Ross D Feldman,Patrice Lindsay,Michael D Hill,Mark Gelfer,Kevin D Burns,Michel Vallée,G V Ramesh Prasad,Marcel Lebel,Donna McLean,J Malcolm O Arnold,Gordon W Moe,Jonathan G Howlett,Jean-Martin Boulanger,Pierre Larochelle,Lawrence A Leiter,Charlotte Jones,Richard I Ogilvie,Vincent Woo,Janusz Kaczorowski,Luc Trudeau,Robert J Petrella,Alain Milot,James A Stone,Denis Drouin,Kim L Lavoie,Maxime Lamarre-Cliche,Marshall Godwin,Guy Tremblay,Pavel Hamet,George Fodor,S George Carruthers,George B Pylypchuk,Ellen Burgess,Richard Lewanczuk,George K Dresser,S Brian Penner,Robert A Hegele,Philip A McFarlane,Mukul Sharma,Debra J Reid,Sheldon W Tobe,Luc Poirier,Raj S Padwal,Canadian Hypertension Education Program
DOI: https://doi.org/10.1016/j.cjca.2013.01.005
Abstract:We updated the evidence-based recommendations for the diagnosis, assessment, prevention, and treatment of hypertension in adults for 2013. This year's update includes 2 new recommendations. First, among nonhypertensive or stage 1 hypertensive individuals, the use of resistance or weight training exercise does not adversely influence blood pressure (BP) (Grade D). Thus, such patients need not avoid this type of exercise for fear of increasing BP. Second, and separately, for very elderly patients with isolated systolic hypertension (age 80 years or older), the target for systolic BP should be < 150 mm Hg (Grade C) rather than < 140 mm Hg as recommended for younger patients. We also discuss 2 additional topics at length (the pharmacological treatment of mild hypertension and the possibility of a diastolic J curve in hypertensive patients with coronary artery disease). In light of several methodological limitations, a recent systematic review of 4 trials in patients with stage 1 uncomplicated hypertension did not lead to changes in management recommendations. In addition, because of a lack of prospective randomized data assessing diastolic BP thresholds in patients with coronary artery disease and hypertension, no recommendation to set a selective diastolic cut point for such patients could be affirmed. However, both of these issues will be examined on an ongoing basis, in particular as new evidence emerges.